FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors [Yahoo! Finance]
Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea [USA TODAY]
Why Viking Therapeutics Tumbled by More Than 10% This Week [Yahoo! Finance]
Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week [Yahoo! Finance Canada]
Yahoo Finance [Yahoo! Finance]